Tandem Diabetes (TNDM) Misses Q3 EPS by 28c, Revenues Beat; Offers FY18 Revenue Outlook Above Consensus
Go back to Tandem Diabetes (TNDM) Misses Q3 EPS by 28c, Revenues Beat; Offers FY18 Revenue Outlook Above Consensus| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 22.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.72 | 52 Week High | $12.48 | |||
| Open | $22.72 | 52 Week Low | $1.60 | |||
| Day High | $22.72 | P/E | N/A | |||
| Day Low | $22.72 | EPS | $-6.33 | |||
| Volume | 2,441 | |||||

